PPT-Big Data in the context of the Pharmaceutical Industry

Curtis Smith November 30 2016 Big Data Panel Discussion Big Data and the Pharmaceutical Industry 2 There has been substantial change to the Pharmaceutical data environment over the last 5 years . March 27th 2014, University of Zurich . Fabienne Heimgartner, Interpharma. What. . it. . needs. . for. . one. . drug. CHF . investment. working. . hours. . experiments. scientists. drug. 1 000 000 000. The Global pharmaceutical industry-part-2. The Framework of five forces.. Potential entrants. Substitutes. Buyers. Suppliers. Implication of the five forces. Potentials entrants “Treat of entry”. Quality . and . Environmental Requirements. Expectations from European industry . regarding . collaboration on drug quality and environment. A Global industry acts with global standards. 2. Excellence Builds on Continual Improvement. version. . : . 21/09/. 2015. Growth and competitiveness of the pharmaceutical industry. www.efpia.eu. Growth & Competitiveness. Growth and competiveness - rationale. Why is the pharmaceutical industry a key asset to European competitiveness ? . Including Key Drivers for change and major trends in this industry. POLITICAL FACTORS. Many countries have a ‘monopsony’ where there is one powerful purchaser; the government. Goverments have focused on pharmaceutical companies as easy targets in their efforts to control rising health care expenditure. Methods include price or reimbursement controls.. version. . : . 21/09/. 2015. Growth and competitiveness of the pharmaceutical industry. www.efpia.eu. Growth & Competitiveness. Growth and competiveness - rationale. Why is the pharmaceutical industry a key asset to European competitiveness ? . IPC. 11. th. Dec . 2015, . Geneva. . National Strategy for Pharmaceutical Manufacturing Development in Ethiopia. developing industry to improve access. P. eople everywhere have access to the essential medicines they need; that the medicines are safe, effective, and of good quality; and that the medicines are prescribed and used rationally.. Human Capital Outlook Implications for Skills Development in the Pharmaceutical Sector. Johannesburg. May 27 2015. Disclaimer . Any views or opinions expressed herein are solely those of the author and do not necessarily represent those of any company. T.U. . Federation of Chemical, Glass and Ceramic. . Industries. . in Poland.. Józef Woźny- . President. National . Pharmaceutical Industry plays an important role in the Polish health & care system provides patients with affordable medicines available to treat most illnesses. . March 27th 2014, University of Zurich . Fabienne Heimgartner, Interpharma. What. . it. . needs. . for. . one. . drug. CHF . investment. working. . hours. . experiments. scientists. drug. 1 000 000 000. Curtis Smith. November 30, . 2016. Big Data Panel Discussion. Big . Data and the Pharmaceutical Industry. 2. There has been substantial change to the . Pharmaceutical data . environment over the last 5 years. . 2015, . Geneva. . National Strategy for Pharmaceutical Manufacturing Development in Ethiopia. developing industry to improve access. P. eople everywhere have access to the essential medicines they need; that the medicines are safe, effective, and of good quality; and that the medicines are prescribed and used rationally.. Industry Introduction. Challenges & Opportunities. Industry Introduction. 2010 China’s Health Expenditure was 5.1% of the GDP. From WHO statistic yearbook and . Tengwei. 2013 semiannual summit. Abida Zameer. Harrisburg University. GRAD 699 PGMT. Agenda. Introduction and Problem Statement . Methodology . Results . Discussion. Conclusions. Special . Characterstics. of the pharmaceutical industry .